Antibiotice S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was RON 13.38 million compared to RON 13.78 million a year ago. Net income was RON 80.69 million compared to RON 38.51 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 RON | -2.35% | +4.52% | +49.10% |
May. 15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 28 | Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+49.10% | 304M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- ATB Stock
- News Antibiotice S.A.
- Antibiotice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023